Ascentage Pharma appoints Yiqing Chen as CFO
Ascentage Pharma, based in China, has announced the appointment of Yiqing Chen as Chief Financial Officer (CFO), reporting directly to Dr Dajun Yang, Chairman and Chief Executive Officer (CEO) of Ascentage Pharma. As a member of the company’s senior executive team, Chen will focus his work on the capital market, financial management, and investor relations, to drive the company’s long-term and sustained growth in the capital market. Prior to joining Ascentage Pharma, Chen was Vice CFO and General Manager of Investor Relations and Capital Deployment at Fosun Pharma; and Deputy General Manager and CFO at BGI Genomics for years, having accumulated deep expertise in the capital market and corporate finance. During his tenure at BGI Genomics, Chen accomplished a series of well-known financing projects in the life sciences industry, under the leadership of the company’s Chairman and General Manager. These projects include capital transactions and operational initiatives such as Initial Public Offering (IPO) in mainland China, issuance of corporate debt, refinancing, and restructuring the company’s financial organization.